{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T10:08:07Z","timestamp":1746785287949},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T00:00:00Z","timestamp":1504483200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s00347-017-0562-3","type":"journal-article","created":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T06:52:51Z","timestamp":1504507971000},"page":"959-972","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Diagnostik und Management des Herpes zoster ophthalmicus"],"prefix":"10.1007","volume":"114","author":[{"given":"R. N.","family":"Werner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.-I.","family":"Steinhorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Nast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Pleyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,4]]},"reference":[{"key":"562_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/jdv.13995","volume":"31","author":"RN Werner","year":"2017","unstructured":"Werner RN, Nikkels AF, Marinovic B et al (2017) European consensus-based (S2k) Guideline on the Management of Herpes Zoster \u2013 guided by the European dermatology forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), part 1: diagnosis. J\u00a0Eur Acad Dermatol Venereol 31:9\u201319. https:\/\/doi.org\/10.1111\/jdv.13995","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"562_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/jdv.13957","volume":"31","author":"RN Werner","year":"2017","unstructured":"Werner RN, Nikkels AF, Marinovi CB et al (2017) European consensus-based (S2k) Guideline on the Management of Herpes Zoster \u2013 guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment. J\u00a0Eur Acad Dermatol Venereol 31:20\u201329","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"562_CR3","volume-title":"The AGREE II Instrument","author":"AGREE Next Steps Consortium","year":"2009","unstructured":"AGREE Next Steps Consortium (2009) The AGREE II Instrument"},{"key":"562_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1056\/NEJMcp1302674","volume":"369","author":"JI Cohen","year":"2013","unstructured":"Cohen JI (2013) Herpes zoster. N\u00a0Engl J Med 369:255\u2013263","journal-title":"N Engl J Med"},{"key":"562_CR5","doi-asserted-by":"publisher","first-page":"e1003896","DOI":"10.1371\/journal.ppat.1003896","volume":"10","author":"M Jones","year":"2014","unstructured":"Jones M, Dry IR, Frampton D et al (2014) RNA-seq analysis of host and viral gene expression highlights interaction between varicella zoster virus and keratinocyte differentiation. Plos Pathog 10:e1003896","journal-title":"Plos Pathog"},{"key":"562_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrmicro3215","volume":"12","author":"L Zerboni","year":"2014","unstructured":"Zerboni L, Sen N, Oliver S (2014) Molecular mechanisms of varicella zoster virus pathogenesis. Nat Rev Microbiol 12:197\u2013210","journal-title":"Nat Rev Microbiol"},{"key":"562_CR7","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/BF00916011","volume":"7","author":"AR Hayward","year":"1987","unstructured":"Hayward AR, Herberger M (1987) Lymphocyte responses to varicella zoster virus in the elderly. J\u00a0Clin Immunol 7:174\u2013178","journal-title":"J Clin Immunol"},{"key":"562_CR8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/cid\/cit165","volume":"57","author":"A Moanna","year":"2013","unstructured":"Moanna A, Rimland D (2013) Decreasing incidence of herpes zoster in the highly active antiretroviral therapy era. Clin Infect Dis 57:122\u2013125","journal-title":"Clin Infect Dis"},{"key":"562_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-170","author":"S Pinchinat","year":"2013","unstructured":"Pinchinat S, Cebrian-Cuenca AM, Bricout H, Johnson RW (2013) Similar herpes zoster incidence across Europe: results from a\u00a0systematic literature review. BMC Infect Dis. https:\/\/doi.org\/10.1186\/1471-2334-13-170","journal-title":"BMC Infect. Dis."},{"key":"562_CR10","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1212\/WNL.0b013e3182a3516e","volume":"81","author":"BP Yawn","year":"2013","unstructured":"Yawn BP, Gilden D (2013) The global epidemiology of herpes zoster. Neurology 81:928\u2013930","journal-title":"Neurology"},{"key":"562_CR11","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1001\/archinte.1995.00430150071008","volume":"155","author":"JG Donahue","year":"1995","unstructured":"Donahue JG, Choo PW, Manson JE, Platt R (1995) The incidence of herpes zoster. Arch Intern Med 155:1605\u20131609","journal-title":"Arch Intern Med"},{"key":"562_CR12","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/j.1525-1497.2005.0150.x","volume":"20","author":"RP Insinga","year":"2005","unstructured":"Insinga RP, Itzler RF, Pellissier JM et\u00a0al (2005) The incidence of herpes zoster in a\u00a0United States administrative database. J\u00a0Gen Intern Med 20:748\u2013753","journal-title":"J Gen Intern Med"},{"key":"562_CR13","first-page":"9","volume":"58","author":"RE Hope-Simpson","year":"1965","unstructured":"Hope-Simpson RE (1965) The nature of herpes zoster: a long-term study and a\u00a0new hypothesis. Proc R Soc Med 58:9\u201320","journal-title":"Proc R Soc Med"},{"key":"562_CR14","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1159\/000024949","volume":"41","author":"W Meister","year":"1998","unstructured":"Meister W, Neiss A, Gross G et al (1998) Demography, symptomatology, and course of disease in ambulatory zoster patients. A physician-based survey in Germany. Intervirology 41:272\u2013277","journal-title":"Intervirology"},{"key":"562_CR15","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/00005792-198209000-00003","volume":"61","author":"MW Ragozzino","year":"1982","unstructured":"Ragozzino MW, Melton LJ 3rd, Kurland LT et al (1982) Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) 61:310\u2013316","journal-title":"Medicine (Baltimore)"},{"key":"562_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/2051013615599151","volume":"3","author":"RW Johnson","year":"2015","unstructured":"Johnson RW, Alvarez-Pasquin MJ, Bijl M et al (2015) Herpes zoster epidemiology, management, and disease and economic burden in Europe: a\u00a0multidisciplinary perspective. Ther Adv Vaccines 3:109\u2013120","journal-title":"Ther Adv Vaccines"},{"key":"562_CR17","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.amjmed.2012.09.009","volume":"126","author":"WW Zerngast","year":"2013","unstructured":"Zerngast WW, Paauw DS, O\u2019Connor KM (2013) Varicella zoster with extended prodrome: a\u00a0case series. Am J Med 126:359\u2013361","journal-title":"Am J Med"},{"key":"562_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/j.pain.0000000000000307","volume":"157","author":"HJ Forbes","year":"2016","unstructured":"Forbes HJ, Thomas SL, Smeeth L et al (2016) A systematic review and meta-analysis of risk factors for postherpetic neuralgia. Pain 157:30\u201354","journal-title":"Pain"},{"key":"562_CR19","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1007\/s00347-009-2049-3","volume":"106","author":"U Pleyer","year":"2009","unstructured":"Pleyer U, Metzner S, Hofmann J (2009) Diagnostics and differential diagnosis of acute retinal necrosis. Ophthalmologe 106:1074\u20131082","journal-title":"Ophthalmologe"},{"key":"562_CR20","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.pop.2015.05.007","volume":"42","author":"JL Johnson","year":"2015","unstructured":"Johnson JL, Amzat R, Martin N (2015) Herpes zoster ophthalmicus. Prim Care 42:285\u2013303","journal-title":"Prim Care"},{"key":"562_CR21","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.mayocp.2013.03.014","volume":"88","author":"BP Yawn","year":"2013","unstructured":"Yawn BP, Wollan PC, St Sauver JL, Butterfield LC (2013) Herpes zoster eye complications: rates and trends. Mayo Clin Proc 88:562\u2013570","journal-title":"Mayo Clin Proc"},{"key":"562_CR22","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/BF02770836","volume":"26","author":"W Meister","year":"1998","unstructured":"Meister W, Neiss A, Gross G et\u00a0al (1998) A prognostic score for postherpetic neuralgia in ambulatory patients. Infection 26:359\u2013363","journal-title":"Infection"},{"key":"562_CR23","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1212\/WNL.51.5.1405","volume":"51","author":"M Haanpaa","year":"1998","unstructured":"Haanpaa M, Dastidar P, Weinberg A et\u00a0al (1998) CSF and MRI findings in patients with acute herpes zoster. Neurology 51:1405\u20131411","journal-title":"Neurology"},{"key":"562_CR24","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4103\/0976-3147.131673","volume":"5","author":"N Chaker","year":"2014","unstructured":"Chaker N, Bouladi M, Chebil A et\u00a0al (2014) Herpes zoster ophthalmicus associated with abducens palsy. J\u00a0Neurosci Rural Pract 5:180\u2013182","journal-title":"J Neurosci Rural Pract"},{"key":"562_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-217382","author":"A Chandrasekharan","year":"2017","unstructured":"Chandrasekharan A, Gandhi U, Badakere A, Sangwan V (2017) Orbital apex syndrome as a\u00a0complication of herpes zoster ophthalmicus. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2016-217382","journal-title":"BMJ Case Rep"},{"key":"562_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12348-014-0025-9","volume":"4","author":"R Kahloun","year":"2014","unstructured":"Kahloun R, Attia S, Jelliti B et\u00a0al (2014) Ocular involvement and visual outcome of herpes zoster ophthalmicus: review of 45 patients from Tunisia, North Africa. J\u00a0Ophthalmic Inflamm Infect 4:25","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"562_CR27","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1136\/bjo.85.5.576","volume":"85","author":"S Tyring","year":"2001","unstructured":"Tyring S, Engst R, Corriveau C et\u00a0al (2001) Famciclovir for ophthalmic zoster: a\u00a0randomised aciclovir controlled study. Br J Ophthalmol 85:576\u2013581","journal-title":"Br J Ophthalmol"},{"key":"562_CR28","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1056\/NEJM198306163082404","volume":"308","author":"HH Balfour Jr.","year":"1983","unstructured":"Balfour HH Jr., Bean B, Laskin OL et\u00a0al (1983) Acyclovir halts progression of herpes zoster in immunocompromised patients. N\u00a0Engl J Med 308:1448\u20131453","journal-title":"N Engl J Med"},{"key":"562_CR29","first-page":"367","volume":"18","author":"RD Harley","year":"1987","unstructured":"Harley RD, Stefanyszyn MA, Apt L, Nelson LB (1987) Herpetic canalicular obstruction. Ophthalmic Surg 18:367\u2013370","journal-title":"Ophthalmic Surg"},{"key":"562_CR30","first-page":"933","volume-title":"Ocular infection & Immunity","author":"D Pavan-Langston","year":"1996","unstructured":"Pavan-Langston D, Dunkel E (1996) Varicella-Zoster virus diseases: anterior segement of the eye. In: Pepose JS, Holland GN, Wilhelmus KR (Hrsg) Ocular infection & Immunity. Mosby, St. Louis, S 933\u2013957"},{"key":"562_CR31","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/ICO.0000000000001046","volume":"36","author":"SK Szeto","year":"2017","unstructured":"Szeto SK, Chan TC, Wong RL et\u00a0al (2017) Prevalence of ocular manifestations and visual outcomes in patients with herpes zoster ophthalmicus. Cornea 36:338\u2013342","journal-title":"Cornea"},{"key":"562_CR32","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/ICO.0000000000000338","volume":"34","author":"EM McDonald","year":"2015","unstructured":"McDonald EM, Patel DV, McGhee CN (2015) A prospective study of the clinical characteristics of patients with herpes simplex and varicella zoster keratitis, presenting to a\u00a0New Zealand emergency eye clinic. Cornea 34:279\u2013284","journal-title":"Cornea"},{"key":"562_CR33","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1055\/s-0029-1245338","volume":"227","author":"U Pleyer","year":"2010","unstructured":"Pleyer U, Winterhalter S (2010) Diagnostic and therapeutic aspects of herpes virus associated uveitis. Klin Monbl Augenheilkd 227:407\u2013412","journal-title":"Klin Monbl Augenheilkd"},{"key":"562_CR34","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.ophtha.2009.09.001","volume":"117","author":"MD Tibbetts","year":"2010","unstructured":"Tibbetts MD, Shah CP, Young LH et\u00a0al (2010) Treatment of acute retinal necrosis. Ophthalmology 117:818\u2013824","journal-title":"Ophthalmology"},{"key":"562_CR35","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1136\/bjophthalmol-2012-301983","volume":"97","author":"RW Wong","year":"2013","unstructured":"Wong RW, Jumper JM, McDonald HR et\u00a0al (2013) Emerging concepts in the management of acute retinal necrosis. Br J Ophthalmol 97:545\u2013552","journal-title":"Br J Ophthalmol"},{"key":"562_CR36","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1212\/WNL.0000000000000038","volume":"82","author":"J Breuer","year":"2014","unstructured":"Breuer J, Pacou M, Gauthier A, Brown MM (2014) Herpes zoster as a\u00a0risk factor for stroke and TIA: a\u00a0retrospective cohort study in the UK. Neurology 82:206\u2013212","journal-title":"Neurology"},{"key":"562_CR37","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/cid\/ciu098","volume":"58","author":"SM Langan","year":"2014","unstructured":"Langan SM, Minassian C, Smeeth L, Thomas SL (2014) Risk of stroke following herpes zoster: a\u00a0self-controlled case-series study. Clin Infect Dis 58:1497\u20131503","journal-title":"Clin Infect Dis"},{"key":"562_CR38","doi-asserted-by":"publisher","first-page":"e1001919","DOI":"10.1371\/journal.pmed.1001919","volume":"12","author":"C Minassian","year":"2015","unstructured":"Minassian C, Thomas SL, Smeeth L et al (2015) Acute cardiovascular events after herpes zoster: a self-controlled case series analysis in vaccinated and unvaccinated older residents of the United States. PLoS Med 12:e1001919","journal-title":"PLoS Med"},{"key":"562_CR39","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1212\/WNL.0000000000001409","volume":"84","author":"D Gilden","year":"2015","unstructured":"Gilden D, White T, Khmeleva N et\u00a0al (2015) Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis. Neurology 84:1948\u20131955","journal-title":"Neurology"},{"key":"562_CR40","first-page":"3","volume":"17","author":"KN Naveen","year":"2011","unstructured":"Naveen KN, Tophakane RS, Hanumanthayya K et\u00a0al (2011) A study of HIV seropositivity with various clinical manifestation of herpes zoster among patients from Karnataka. India Dermatol Online\u00a0J 17:3","journal-title":"India Dermatol Online J"},{"key":"562_CR41","first-page":"60","volume":"84","author":"L Sharvadze","year":"2006","unstructured":"Sharvadze L, Tsertsvadze T, Gochitashvili N et\u00a0al (2006) Hiv prevalence among high risk behavior group persons with herpes zoster infection. Georgian Med News 84:60\u201364","journal-title":"Georgian Med News"},{"key":"562_CR42","doi-asserted-by":"publisher","first-page":"e52845","DOI":"10.1371\/journal.pone.0052845","volume":"8","author":"AK Sullivan","year":"2013","unstructured":"Sullivan AK, Raben D, Reekie J et al (2013) Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study). PLOS ONE 8:e52845","journal-title":"PLOS ONE"},{"key":"562_CR43","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3109\/02713688709020090","volume":"6","author":"M Cobo","year":"1987","unstructured":"Cobo M, Foulks GN, Liesegang T et\u00a0al (1987) Observations on the natural history of herpes zoster ophthalmicus. Curr Eye Res 6:195\u2013199","journal-title":"Curr Eye Res"},{"key":"562_CR44","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/0002-9343(88)90508-6","volume":"85","author":"JC Huff","year":"1988","unstructured":"Huff JC, Bean B, Balfour HH Jr. et\u00a0al (1988) Therapy of herpes zoster with oral acyclovir. Am J Med 85:84\u201389","journal-title":"Am J Med"},{"key":"562_CR45","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1136\/bmj.293.6561.1529","volume":"293","author":"MW McKendrick","year":"1986","unstructured":"McKendrick MW, McGill JI, White JE, Wood MJ (1986) Oral acyclovir in acute herpes zoster. Br Med J (Clin Res Ed) 293:1529\u20131532","journal-title":"Br Med J (Clin Res Ed)"},{"key":"562_CR46","first-page":"93","volume":"102","author":"P Morton","year":"1989","unstructured":"Morton P, Thomson AN (1989) Oral acyclovir in the treatment of herpes zoster in general practice. N\u00a0Z Med\u00a0J 102:93\u201395","journal-title":"N Z Med J"},{"key":"562_CR47","doi-asserted-by":"publisher","first-page":"89","DOI":"10.7326\/0003-4819-123-2-199507150-00002","volume":"123","author":"S Tyring","year":"1995","unstructured":"Tyring S, Barbarash RA, Nahlik JE et al (1995) Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group. Ann Intern Med 123:89\u201396","journal-title":"Ann Intern Med"},{"key":"562_CR48","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/clinids\/22.2.341","volume":"22","author":"MJ Wood","year":"1996","unstructured":"Wood MJ, Kay R, Dworkin RH et al (1996) Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a\u00a0meta-analysis of placebo-controlled trials. Clin Infect Dis 22:341\u2013347","journal-title":"Clin Infect Dis"},{"key":"562_CR49","first-page":"79","volume":"85","author":"MJ Wood","year":"1988","unstructured":"Wood MJ, Ogan PH, McKendrick MW et\u00a0al (1988) Efficacy of oral acyclovir treatment of acute herpes zoster. Am J Med 85:79\u201383","journal-title":"Am J Med"},{"issue":"Pt 6","key":"562_CR50","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/eye.1994.170","volume":"8","author":"C Neoh","year":"1994","unstructured":"Neoh C, Harding SP, Saunders D et\u00a0al (1994) Comparison of topical and oral acyclovir in early herpes zoster ophthalmicus. Eye (Lond) 8(Pt 6):688\u2013691","journal-title":"Eye (Lond)"},{"key":"562_CR51","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1128\/AAC.39.7.1546","volume":"39","author":"KR Beutner","year":"1995","unstructured":"Beutner KR, Friedman DJ, Forszpaniak C et\u00a0al (1995) Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 39:1546\u20131553","journal-title":"Antimicrob Agents Chemother"},{"key":"562_CR52","first-page":"138","volume":"34","author":"WR Lin","year":"2001","unstructured":"Lin WR, Lin HH, Lee SS et\u00a0al (2001) Comparative study of the efficacy and safety of valaciclovir versus acyclovir in the treatment of herpes zoster. J\u00a0Microbiol Immunol Infect 34:138\u2013142","journal-title":"J Microbiol Immunol Infect"},{"key":"562_CR53","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/j.1346-8138.2012.01584.x","volume":"39","author":"F Ono","year":"2012","unstructured":"Ono F, Yasumoto S, Furumura M et\u00a0al (2012) Comparison between famciclovir and valacyclovir for acute pain in adult Japanese immunocompetent patients with herpes zoster. J\u00a0Dermatol 39:902\u2013908","journal-title":"J Dermatol"},{"key":"562_CR54","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S1386-6532(03)00164-1","volume":"29","author":"SD Shafran","year":"2004","unstructured":"Shafran SD, Tyring SK, Ashton R et al (2004) Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a\u00a0randomized, multicenter, double-blind clinical trial. J\u00a0Clin Virol 29:248\u2013253","journal-title":"J Clin Virol"},{"key":"562_CR55","first-page":"75","volume":"37","author":"MC Shen","year":"2004","unstructured":"Shen MC, Lin HH, Lee SS et al (2004) Double-blind, randomized, acyclovir-controlled, parallel-group trial comparing the safety and efficacy of famciclovir and acyclovir in patients with uncomplicated herpes zoster. J\u00a0Microbiol Immunol Infect 37:75\u201381","journal-title":"J Microbiol Immunol Infect"},{"key":"562_CR56","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/archfami.9.9.863","volume":"9","author":"SK Tyring","year":"2000","unstructured":"Tyring SK, Beutner KR, Tucker BA et\u00a0al (2000) Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older. Arch Fam Med 9:863\u2013869","journal-title":"Arch Fam Med"},{"key":"562_CR57","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0166-3542(03)00065-2","volume":"59","author":"SW Wassilew","year":"2003","unstructured":"Wassilew SW, Wutzler P, Brivddin Herpes Zoster Study G (2003) Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a\u00a0randomized, double-blind, multicentered study. Antiviral Res 59:49\u201356","journal-title":"Antiviral Res"},{"key":"562_CR58","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/S0161-6420(00)00222-0","volume":"107","author":"J Colin","year":"2000","unstructured":"Colin J, Prisant O, Cochener B et\u00a0al (2000) Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus. Ophthalmology 107:1507\u20131511","journal-title":"Ophthalmology"},{"key":"562_CR59","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1056\/NEJM198601233140404","volume":"314","author":"DH Shepp","year":"1986","unstructured":"Shepp DH, Dandliker PS, Meyers JD (1986) Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabine. N\u00a0Engl J Med 314:208\u2013212","journal-title":"N Engl J Med"},{"key":"562_CR60","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/jmv.1890460315","volume":"46","author":"P Wutzler","year":"1995","unstructured":"Wutzler P, De Clercq E, Wutke K, Farber I (1995) Oral brivudin vs. intravenous acyclovir in the treatment of herpes zoster in immunocompromised patients: a\u00a0randomized double-blind trial. J\u00a0Med Virol 46:252\u2013257","journal-title":"J Med Virol"},{"key":"562_CR61","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1056\/NEJM199804233381702","volume":"338","author":"A Lambiase","year":"1998","unstructured":"Lambiase A, Rama P, Bonini S et\u00a0al (1998) Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N\u00a0Engl J Med 338:1174\u20131180","journal-title":"N Engl J Med"},{"key":"562_CR62","volume-title":"Cancer pain relief : with a\u00a0guide to opioid availability","author":"World Health Organization","year":"1996","unstructured":"World Health Organization (1996) Cancer pain relief : with a\u00a0guide to opioid availability, 2.\u00a0Aufl. WHO, Geneva","edition":"2"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-017-0562-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-017-0562-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-017-0562-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T00:39:16Z","timestamp":1602895156000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-017-0562-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,4]]},"references-count":62,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["562"],"URL":"https:\/\/doi.org\/10.1007\/s00347-017-0562-3","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,4]]}}}